Eli Lilly (LLY) reported Q4 non-GAAP earnings Thursday of $5.32 per diluted share, up from $2.49 a year earlier.
Analysts polled by FactSet expected $5.01.
Revenue for the quarter ended Dec. 31 was $13.53 billion, up from $$9.35 billion a year earlier.
Analysts surveyed by FactSet expected $13.53 billion.
For 2025, the company said it expects non-GAAP EPS of $22.50 to $24 on revenue of $58 billion to $61 billion.
Analysts polled by FactSet expect non-GAAP EPS of $22.76 on $58.77 billion in revenue.
The company's shares were up nearly 3% in recent Thursday premarket activity.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。